Tue.Feb 18, 2025

article thumbnail

STAT+: XRHealth makes another acquisition, aiming to be a leading virtual provider using VR

STAT

XRHealth is on a shopping spree, buying three companies in as many years, as it aims to build a leading platform for therapeutic virtual reality. The latest: It’s acquiring RealizedCare, a company that couples immersive experiences with coaches for chronic pain management. XRHealth and RealizedCare own assets for a range of virtual reality headset-based experiences designed to help treat mental health, chronic pain, and other conditions.

182
182
article thumbnail

Medicines shortages causing 'moral injury', suggests RPS survey

The Pharmacist

Pharmacists are experiencing 'moral injury' with more than half of pharmacy professionals reporting that medicines shortages have impacted their mental health and wellbeing, according to the Royal Pharmaceutical Society (RPS). Its most recent workforce wellbeing survey also found that inadequate staffing was affecting wellbeing for 70% of pharmacy professionals, with just 35% of pharmacists able […] The post Medicines shortages causing 'moral injury', suggests RPS survey appeared

122
122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Abridge raises $250 million highlighting ‘billable notes’

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Bill, baby, bill: Abridge announces $250 million raise Abridge announced a $250 million Series D fundraise co-led by investor Elad Gil and IVP with participation from many other notable venture firms.

article thumbnail

Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData

Express Pharma

The fragile X syndrome (FXS) market across the US and Germany is projected to experience explosive growth, quadrupling from $28.7 million in 2025 to $111.9 million by 2030, a CAGR of 31.3 per cent (2025-2030), driven by the anticipated launch of two high-priced targeted therapies for FXS in 2027, according to GlobalData. GlobalDatas latest report, Fragile X Syndrome: Opportunity Assessment and Forecast -Update, anticipates a stable market until the projected US launches of Harmony Biosciences Zy

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Could SSRIs protect against infections? A mouse study has hints

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning, we’ve got a lot to go over. As one editor put it on Friday: “‘When it rains it pours’ doesn’t seem to adequately capture the deluge of news.

246
246

More Trending

article thumbnail

Biogen partners with Stoke Therapeutics to sell severe epilepsy drug

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning. Today we take a closer look at what firings at U.S. health agencies mean for the country’s broader scientific enterprise. Also, a hearty congrats to my coworkers Bob Herman, Tara Bannow, Casey Ross, and Lizzy Lawrence, who won a Polk award — STAT’s third — for their coverage of UnitedHealth Group.

article thumbnail

Vanishing Act: Why Small Pharmacies Exited Medicare Part D Networks for 2025

Drug Channels

Abracadabra! Small pharmacies have ghosted Medicare Part Ds preferred networksno farewell party, no breakup text, just a quiet exit. A few months ago , DCI highlighted how the largest pharmacy chains are participating as preferred cost sharing pharmacies in the 2025 stand-alone prescription drug plan (PDP) networks. Today, we update our exclusive analysis of how smaller pharmacies are participating via their pharmacy services administrative organizations (PSAOs).

article thumbnail

FDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoid

Pharmaceutical Technology

As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues.

105
105
article thumbnail

Can Dupixent plug treatment gap in bullous pemphigoid?

pharmaphorum

The FDA is scheduled to deliver a verdict on Sanofi and Regeneron's Dupixent for rare autoimmune skin disorder bullous pemphigoid in June

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

NHS England launches first-ever breast cancer screening campaign

Pharma Times

New data has shown that around a third of women do not attend screenings after being invited

83
article thumbnail

Four more drugs in keenly watched ALS trial miss the mark

pharmaphorum

ALS candidates from Biohaven, Prilenia, Clene, and UCB were unable to slow disease progression in the study, but two showed signs of efficacy

77
article thumbnail

Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use

Pharmaceutical Technology

The FDA has accepted Gileads new drug application with a decision expected by 19 June 2025.

71
article thumbnail

First biosimilar fast-acting insulin reaches US market

pharmaphorum

Sanofi has claimed FDA approval for the first biosimilar of Novo Nordisk's rapid-acting insulin analogue Novolog

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The Role of Collaborative Supply Chains in Improving Patient Outcomes

Pharmaceutical Commerce

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of sales, life sciences, Loftware, comments on why she believes supply chain collaboration is becoming increasingly critical today.

69
article thumbnail

Behind the Headlines Episode 11–GLP-1 Patent Expiry, Recent Acquisitions, and Indirect Costs Capping

PharmaTech

Benjamin McLeod, Abhi Naravane, PhD, MBA, and Marianna Tcherpakov PhD go behind the headlines to talk about the latest big acquisitions, GLP-1 Super Bowl advertising, and changes in NIH funding.

64
article thumbnail

Valneva hits 2024 sales target but plans lower cash burn in 2025

Pharmaceutical Technology

Product sales for the vaccine specialist Valneva reached 170m despite slow US sales of its chikungunya vaccine.

article thumbnail

Biogen buys rights to Stoke’s rare epilepsy drug

BioPharma Dive

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet syndrome.

64
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

IP Litigator Publishes Goodwin Partners’ BPCIA Research

Big Molecule Watch

Huiya Wu and Michael Siekman’s article, Are Reference Product Sponsors Asserting More Patents in BPCIA Litigation? was recently published in the IP Litigator’s February Issue. The IP Litigator is an online publication that provides regular updates on the latest strategies for handling intellectual property (IP) lawsuits and enforcement.

59
article thumbnail

Solid says early data suggest ‘differentiated’ Duchenne gene therapy

BioPharma Dive

The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including Sarepta Therapeutics’ Elevidys.

64
article thumbnail

FDA grants fast track status to Rznomics’ RZ-001 for HCC

Pharmaceutical Technology

The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatment of hepatocellular carcinoma (HCC).

59
article thumbnail

GSK’s 5-in-1 meningococcal shot wins FDA approval

BioPharma Dive

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through 25 years old.

63
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

HMRI and Novartis Australia sign MoU to expedite medical research

Pharmaceutical Technology

HMRI has signed a memorandum of understanding (MoU) with Novartis Australia for expediting medical research to drive healthcare projects.

59
article thumbnail

Shionogi gets approval in Japan for ADHD digital therapeutic

pharmaphorum

Shionogi will market the EndeavorRide app, originally licensed from Akili, in Japan following its approval by the MHLW regulator

57
article thumbnail

PharmD Live Releases White Paper on Pharmacist-Led Virtual Care to Maximize Shared Savings for Payviders

PharmD Live

WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent white paper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics. The paper demonstrates how clinical pharmacist-led virtual care improves medication adherence, reduces hospital readmissions and enhances value-based care metrics, driving financial and clinical success for healthcare organizations.

article thumbnail

NHC CEO Affinity Group Meeting

Putting Patients First Blog

February NHC CEO Affinity Group Meeting Event Time: 4:00 - 5:00 p.m. ET Event Location: Virtual This virtual gathering is intended to support peer-to-peer conversation among NHC CEOs on topics of interest, in this case, the impact of the current political environment on patient organizations. Participation is reserved for CEOs of NHC patient and partner of patient organization members.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.